-
Indonesian court hears 'negligence' complaint against state over fires, haze
-
Germany factory production at highest level for 18 months
-
Rubio in Greece to urge against Western civilisation 'decline'
-
Thailand floods death toll rises to 60 since mid-September
-
Micron workers at Taiwan plant vote in favour of strike
-
US pushes Russia for information on plague reports
-
In 'The Social Reckoning,' Jeremy Allen White takes on Facebook's 'frightening' ambition
-
Myanmar leader lands in Malaysia for migrant return talks
-
Chip industry activists call for South Korea to recognise cancer cases
-
Indian central bank hikes rates for first time since 2023
-
Famine-scarred southern Madagascar braces for El Nino
-
US military on Okinawa face curfew, alcohol ban after murder case
-
How the EU regulates lobbyists
-
Fierce lobbying in EU over 'forever chemicals'
-
I.Coast refuge offers lifelong care for youngsters scorned as 'sorcerers'
-
Dodgers beat Braves and Padres avoid sweep in MLB playoffs
-
Indian central bank hikes rates for first time in more than 3 years
-
Mourning, war and elections as Israel marks October 7
-
Hotel Blacklist Launches New Accommodation Industry Risk Assessment Tool
-
Messi says Argentina retirement is 'saddest day of my career'
-
Bangladesh nuclear plant draws hope -- and worry
-
Oil rises and stocks fall as Hormuz worries flare
-
US beat Canada 1-0 to wrap up four-win international break
-
Pacific presses world for help 'surviving' climate change at pre-COP summit
-
Turkey, Australia's joint COP31 leadership raises doubts
-
Verstappen revival to be put to the test in steamy Singapore
-
For Turkish NGOs, COP31 offers rare space for action
-
US woman who survived botched execution is conscious, speaking: lawyers
-
Sleep, appetite, gene-editing experts contend for Nobel chemistry prize
-
Climate champion Australia digging more coal
-
Nobel Peace Prize haunted by the 'spectre' of Trump
-
Emotion, tears as Messi retires from Argentina national team
-
Africa launches own credit agency in bid for cheaper borrowing
-
Dodgers push Braves to the brink of MLB playoff exit
-
US, China, EU: three paths to regulating AI
-
Crisis-stricken Haiti postpones elections
-
Australia's High Court rules against coal mine in landmark climate case
-
N. Korea's Kim pledges 'invariable support' in Putin birthday letter
-
Australia touts new funds for Pacific infrastructure at Fiji 'pre-COP'
-
OGRD Alliance Advances PLPC Multi-Asset Platform Following APHELAR Milestone, Expanding Licensing and Strategic Capital Frameworks
-
Eva Marie Saint, Oscar winner of Hollywood classics, dies at 102
-
Emotion, tears as Messi prepares for Argentina farewell
-
Australia probes app used in cheap smart glasses over privacy fears
-
Kane eyes Ronaldo record after matching England cap mark
-
England needed to 'move on' from World Cup pain, says Tuchel
-
Spain fight back to beat Croatia, Kane adds to record for England
-
O'Neill to stay at Celtic after period of "reflection"
-
Merino double helps Spain beat Croatia, reach Nations League quarters
-
Kane marks 125th England cap with Wembley Nations League double
-
US stocks hit fresh records as oil stabilizes on rising supplies
Cervical cancer vaccine push has saved 1.4 million lives: Gavi
A three-year campaign to bring vaccines against human papillomavirus (HPV) to low-income countries has prevented 1.4 million cervical cancer deaths, the vaccine alliance Gavi said Monday.
"An estimated 86 million girls are now protected against the leading cause of cervical cancer, thanks to a concerted three-year effort by Gavi, the Vaccine Alliance and lower-income countries," the organisation said.
It added in a statement to mark World Cervical Cancer Elimination Day that "an estimated 1.4 million future deaths" had been prevented.
Cancer caused by HPV disproportionately affects low-income countries, which often lack screening services and access to treatment.
These countries accounted for 90 percent of the 350,000 cervical cancer deaths recorded in 2022, according to Gavi.
The organisation's chief executive Sania Nishtar credited the "incredible commitment" by countries and organisations for helping to reach the target of protecting 86 million girls.
Gavi said that across Africa the coverage rate for the vaccine had risen from four percent of girls in 2014 to 44 percent at the end of 2024, higher than for Europe on 38 percent.
The alliance said it used economies of scale to bring down prices and make vaccines available to about 50 poorer countries.
"Gavi secured commitments from manufacturers to invest in HPV vaccines -– and the price of HPV vaccines in Gavi-supported countries is now between $2.90 and $5.18 per dose, compared with US$100 or more elsewhere," said the statement.
"This collaborative effort is driving major global progress towards eliminating one of the deadliest diseases affecting women," she said, while stressing that the cancer still kills a woman every two minutes.
The World Health Organization (WHO) officially backed a single-dose HPV vaccination schedule instead of the previous two doses in 2022, allowing twice as many girls to be vaccinated with existing stocks.
L.Hussein--SF-PST